News
A world-first trial of a gene therapy to cure a form of deafness has begun, potentially heralding a revolution in the treatment of hearing loss. Up to 18 children from the UK, Spain, and the US ...
While some of the conditions are genetic and can be inherited, other forms are acquired and immune mediated. "It can be your immune system, unfortunately, attacking different parts of the nerve or ...
The Food and Drug Administration on Thursday approved Amgen's treatment for patients with the most deadly form of lung cancer. The agency cleared the drug, called Imdelltra, as a second or later ...
Starting hormone therapy earlier than 60 and continuing treatment doesn’t pose as much of a risk, but long-term HRT has greater risks the longer you continue with treatment.
King Charles cancels engagements after experiencing temporary side effects of cancer treatment - CNN
Britain’s King Charles “required a short period of observation in hospital” on Thursday after experiencing “temporary side effects” from a scheduled cancer treatment in the morning ...
A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.
MAIA Biotechnology's Phase 2 THIO-101 trial shows promising updates for THIO with Regeneron's cemiplimab in advanced NSCLC patients. Results include a 38% ORR, 85% DCR, and lower toxicity, with ...
If starting or continuing treatment with Wegovy will improve your health, appealing an insurance denial is a good idea. According to research from 2021, around 41% of healthcare-related denial ...
BACKGROUND: Despite the well-documented success of behavioral techniques in producing temporary weight loss, treatment is typically followed by weight regain. The maintenance of treatment effects ...
Adherence rates differed from 7 to 12 months, with only 8.2% of those receiving testosterone cypionate continuing treatment at 12 months compared with 41.9% for testosterone undecanoate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results